Articles

Demand for excellent uncorrected distance visual acuity after cataract surgery is increasing, especially with the availability of new presbyopia-correcting IOLs. This phenomenon is opening up a new class of patients to the benefits of laser vision correction.

Topical therapy to treat posterior segment disease is possible despite the limitations of the blood-retinal barrier.

Topography-guided LASIK, used with a comprehensive eye scanner (Pentacam, Oculus), has been very successful in minimizing severe corneal distortions and offers reliable registration in most cases.

The results of the PrONTO Study, an exploratory open-label trial, indicated that intravitreal injection of ranibizumab (Lucentis, Genentech) produces rapid improvements in visual acuity and findings on optical coherence tomography (OCT) in patients treated for neovascular age-related macular degeneration.

As the evolution in refractive surgery continues, surgeons can expect to see the journey continuing back to the surface—aided by new strategies to improve the outcomes of sub-Bowman's keratomileusis (SBK) and PRK.

VEGF Trap (Regeneron Pharmaceuticals) has been seen in two studies (CLEAR-IT AMD 1 and CLEAR-IT AMD 2) to be safe, bioefficacious, and tolerated in the eyes of patients with neovascular age-related macular degeneration.

Advanced Medical Optics (AMO) continues its commitment to the LASIK industry by reaching out to a generation of nearly 290 million people worldwide who want better everyday vision.

New extended delivery methods are under development and in the future should facilitate more effective administration of numerous types of ocular agents.

Results of retrospective studies of eyes undergoing surface ablation treatments at the Cole Eye Institute, Cleveland Clinic, Cleveland, OH, are suggesting an algorithm for using mitomycin-C (MMC) to prevent haze.

A review of November's product news

A review of this month's research news

A review of November's industry news

Preview of this year's AAO meeting in New Orleans, including city and dining guides and all the show information you will need.

When we launched Ophthalmology Times Europe (OTE) two years ago, our aim was always to provide a forum for ophthalmologists to communicate their knowledge, discoveries, experience and opinions. This aim has not changed. However, with the industry evolving at such a dramatic rate, it is difficult to convey the views and opinions of everyone who wants to be heard in our print publication. Help is at hand.

Circumferential viscodilation and tensioning of Schlemm's canal is a safe and effective surgical procedure for reducing intraocular pressure in adult patients with open-angle glaucoma.

Spectral (fourier domain) optical coherence tomography (SOCT) represents a significant development in the field of retinal imaging.

Advanced Medical Optics (AMO) has entered into a US patent license agreement with Carl Zeiss Meditec.

Alimera Sciences and pSivida have completed enrolment for the FAME (Fluocinolone Acetonide in diabetic Macular Edema) study of Medidur.

Randomized data from a large cohort of women with cardiovascular disease or at a high risk of it indicate that seven years of daily supplementation with folic acid, vitamin B6, and vitamin B12 may reduce the risk of age-related macular degeneration (AMD), according to William G. Christen, ScD, PhD.

Researchers have identified the gene responsible for binocular vision.

A new pressure-to-cornea index (PCI) has been created in an attempt to integrate intraocular pressure (IOP) and central corneal thickness (CCT) into a unified risk factor.

Aspheric intraocular lenses induce less wavefront aberrations and perform better in photopic and mesopic conditions than spherical IOLs.

A new preloaded disposable intraocular lens (IOL) injector that uses no viscoelastic was unveiled at the Asia-Pacific Association of Cataract and Refractive Surgeons meeting held, this year, in Vietnam.

A study published in the September issue of the Journal of Cataract and Refractive Surgery suggests that a laser welding technique could offer a good alternative to suturing for closing corneal wounds following phaco or extracapsular cataract extraction.

A variant form of vascular endothelial growth factor (VEGF) has been discovered to be responsible for the inflammation and altered retinal vascularization that occurs in conditions such as diabetic retinopathy.

An artificial cornea based on a commercially available polymer, may be ready for clinical testing early in 2008.

The National Aeronautics and Space Agency (NASA) has approved AMO's LASIK technologies for use on US astronauts.

The glaucoma-specific health-related quality of life questionnaire, Glau-Qol, demonstrates good correlations with disease progression in patients with glaucoma and ocular hypertension.

Carl Zeiss Meditec has now completed its acquisition of Acri.Tec AG.

25-gauge pars plana vitrectomy (PPV) appears to be safe and effective for the treatment of epiretinal membranes.